Development of bio-artficial skin composed of autologous keratinocytes layered on cryopreserved allogeneic cultured dermal substitute and its clinical application

冻存同种异体培养真皮替代物上自体角质细胞层积生物人工皮肤的研制及其临床应用

• 批准号: 12558111
• 负责人: KUROYANAGI Yoshimitsu
• 金额: $ 6.53万
• 依托单位: KITASATO UNIVERSITY
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (B)
• 财政年份: 2000
• 资助国家: 日本
• 起止时间: 2000 至 2003
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-12558111/
• 关键词: keratinocytes; fibroblasts; hyaluronic acid; collagen; cultured dermal substitute; cultured skin; 繊維芽細胞; バイオ人工皮膚; 同種培養真皮; 血管内皮成長因子; フィブロネクチン; 培養表皮

Allogeneic cultured dermal substitute (CDS) was prepared by culturing fibroblasts on a 2-layered spongy matrix of hyaluronic acid (HA) and atelo-collagen (Col). Allogeneic CDS can be cryopreserved and transported to other hospitals in a frozen state. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), platelet derived growth factor (PDGF)-AA, transforming growth factor (TGF)-β1, keratinocytes growth factor (KGF), interleukin (IL)-6, and IL-8 were contained in the culture medium which used in preparing CDS over a cultivation period of 1 week (fresh CDS culture medium sample). After thawing a cryopreserved CDS, the CDS was rye-cultured in a culture medium for 1 week. VEGF, bFGF, HGF, TGF-β1, and IL-8 were contained in the culture medium which used in rye-culturing CDS for 1 week (cryopreserved CDS culture medium sample), although some cytokines were detected in lower level than those before freezing. This finding suggests that the cryopreserved CDS retains its ability to release these cytokines.Clinical research on allogeneic CDS, which was newly developed at the R&D Center for Artificial Skin of Kitasato University, has been carried out in medical centers across Japan. It was demonstrated that the allogeneic CDS functions as an excellent cell therapy for intractable skin ulcers as well as bum injuries. The spongy matrix itself as well as the cytokines released firm the allogeneic CDS seemed to be beneficial for the treatment of intractable skin defect. To expand this clinical application, we developed an advanced cultured skin substitute, bio-artificial skin, which is composed of autologous keratinocytes layered on a cryopreserved CDS. Wye found with animal test using athymic mouse that this bio-artficial skin take successfully

通过在透明质酸（HA）和间质胶原（Col）两层海绵基质上培养成纤维细胞制备同种异体培养真皮替代物（CDS）。异体CDS可以冷冻保存，并在冷冻状态下运送到其他医院。制备CDS所用的培养基中含有血管内皮生长因子（VEGF）、碱性成纤维细胞生长因子（bFGF）、肝细胞生长因子（HGF）、血小板衍生生长因子(PDGF)-AA、转化生长因子(TGF)-β1、角质形成细胞生长因子（KGF）、白细胞介素(IL)-6、IL-8，培养周期为1周（新鲜CDS培养基样品）。冷冻保存的CDS解冻后，在培养基中黑麦培养1周。黑麦培养CDS 1周的培养基（冷冻保存的CDS培养基样品）中含有VEGF、bFGF、HGF、TGF-β1和IL-8，但部分细胞因子的检测水平低于冷冻前。这一发现表明，冷冻保存的CDS保留了释放这些细胞因子的能力。北中大学人造皮肤研究开发中心最近开发的异体CDS临床研究已经在日本各地的医疗中心展开。结果表明，同种异体CDS是治疗顽固性皮肤溃疡和烧伤的一种很好的细胞疗法。海绵基质本身以及异体CDS释放的细胞因子似乎有利于治疗顽固性皮肤缺损。为了扩大这一临床应用，我们开发了一种先进的培养皮肤替代品，生物人工皮肤，它是由自体角质形成细胞分层在冷冻保存的CDS上组成的。通过胸腺小鼠的动物实验，我们发现这种生物人造皮肤效果良好

项目成果

Y.Kuroyanagi, K.Kubo et al.: "Establishment of banking system for allogeneic cultured dermal substitute"Artificial Organs. 28. 13-21 (2004)

Y.Kuroyanagi、K.Kubo 等人：“同种异体培养真皮替代品银行系统的建立”人工器官。

Kentaro Kubo, Yoshimitsu Kuroyanagi: "Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute : evaluation in an animal test."J.Artif.Organs. 6. 64-70 (2003)

Kentaro Kubo、Yoshimitsu Kuroyanagi：“透明质酸和胶原蛋白的海绵基质作为培养真皮替代品：动物试验中的评估。”J.Artif.Organs。

黒柳 能光: "特集;再生医療(皮膚を対象とした再生医療)[分担]"日本臨床. 542 (2003)

黑柳义光：“专题；再生医学（针对皮肤的再生医学）[合著者]”日本临床实践 542 (2003)。

Kentaro Kubo, Yoshimitsu Kuroyanagi: "Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro."J.Artif.Organs. 6. 267-272 (2003)

Kentaro Kubo、Yoshimitsu Kuroyanagi：“培养真皮替代物释放的血管内皮生长因子对体外血管内皮细胞增殖的影响。”J.Artif.Organs。

K.Kubo, Y.Kuroyanagi: "Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro"J.Artif.Organs. 6. 267-272 (2003)

K.Kubo、Y.Kuroyanagi：“培养真皮替代物释放的血管内皮生长因子对体外血管内皮细胞增殖的影响”J.Artif.Organs。